Product Information
CIPROFLOXACIN 0.3% EYE DROP is a generic product labeled by Sandoz Inc., priced at $0.7964 per ML under NDC 61314065610. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 31, 1990. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the Ciprofloxacin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/mL
Manufacturer
Sandoz Inc.NDC
61314065610
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
CIPROFLOXACIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019992FDA Approved
12/31/1990
TE Code
AT
On Market Since
5/7/2004
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACIN 0.3% EYE DROP has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 16.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7964 per ML |
|---|---|
| All-time high | $2.8216 (Feb 12, 2020) |
| All-time low | $0.6394 (Oct 22, 2014) |
| 52-week high | $1.2740 |
| 52-week low | $0.7964 |
| Median price | $1.0608 |
| Average price | $1.2038 |
| Largest weekly change | +56.3% (May 22, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ciprofloxacin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACIN 0.3% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACIN 0.3% EYE DROP, manufactured by Sandoz Inc., is $0.7964 per ML (NDC 61314065610), effective Sep 30, 2026.
How has the price of CIPROFLOXACIN 0.3% EYE DROP changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has declined 16.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACIN 0.3% EYE DROP?
Since Nov 28, 2013, the NADAC for CIPROFLOXACIN 0.3% EYE DROP has ranged from a low of $0.6394 (Oct 22, 2014) to a high of $2.8216 (Feb 12, 2020), with a median of $1.0608 per ML.
Are there cheaper alternatives to CIPROFLOXACIN 0.3% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIPROFLOXACIN 0.3% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures CIPROFLOXACIN 0.3% EYE DROP?
CIPROFLOXACIN 0.3% EYE DROP (NDC 61314065610) is labeled by Sandoz Inc., and CMS classifies it as a generic product.